Top Markets
Coin of the day
Skye Bioscience, Inc. Skye Bioscience, Inc.

Skye Bioscience, Inc.

SKYE
Classement en actions #31353
Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on... Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on developing molecules that modulate G-protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases. Its lead product candidate is nimacimab, a peripherally restricted negative allosteric modulating antibody targeting cannabinoid receptor 1, a key GPCR involved in metabolic regulation. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. Skye Bioscience, Inc. is headquartered in San Diego, California.
Prix de l'action
$0.4018
Capitalisation boursière
$14.12M
Changement (1 jour)
-3.20%
Changement (1 an)
-88.15%
Pays
US
Échange Skye Bioscience, Inc. (SKYE)

Catégorie

Historique du prix de l'action pour Skye Bioscience, Inc. (SKYE)
Prix de clôture le plus élevé : $0.50 le 2026-08-01

Prix de clôture le plus bas : $2.50K le 2014-11-01
Historique du prix de l'action de Skye Bioscience, Inc. de 2014 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) 27.55%
2025 -68.43%
2024 7.82%
2023 -19.28%
2022 -74.81%
2021 58.02%
2020 -81.19%
2019 -44.44%
2018 157.69%
2017 -64.63%
2016 -42.36%
2015 -92.76%
2014 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$532.17 36.50%
US
$1.00K 51.81%
NL
$111.31 -36.83%
AU
$735.86 6.87%
CH
$257.75 13.01%
BE